Clinical Trials Directory

Trials / Terminated

TerminatedNCT01415947

V-Chordal Adjustable System for Chordal Replacement in Mitral Valve Insufficiency Due to Leaflet Prolapse

Status
Terminated
Phase
Phase 2
Study type
Interventional
Enrollment
5 (actual)
Sponsor
Edwards Lifesciences · Industry
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The V-Chordal System is a new technology for mitral repair. The Valtech V-Chordal system, consists in the ability to adjust (elongate or shorten) the neochordae "off-pump" to achieve an optimal coaptation. The adjustment mechanism allows overcoming the main problem of chordal replacement by enabling accurate sizing of the chords.

Conditions

Interventions

TypeNameDescription
DEVICEV ChordalV-Chordal system, consists in the ability to adjust (elongate or shorten) the neochordae "off-pump" . The adjustment mechanism allows overcoming the main problem of chordal replacement by enabling accurate sizing of the chords.

Timeline

Start date
2010-11-01
Primary completion
2012-05-01
Completion
2013-03-01
First posted
2011-08-12
Last updated
2014-12-23

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT01415947. Inclusion in this directory is not an endorsement.